Veterinary Medicines

PARACOX-5, SUSPENSION FOR ORAL SUSPENSION FOR CHICKENS

Authorised
  • Eimeria maxima, strain CP, Live
  • Eimeria tenella, strain HP, Live
  • Eimeria mitis, strain HP, Live
  • Eimeria maxima, strain MFP, Live
  • Eimeria acervulina, strain HP, Live
Download as PDF

Product identification

Medicine name:
PARACOX-5, SUSPENSION FOR ORAL SUSPENSION FOR CHICKENS
Paracox-5 Suspensie voor suspensie voor oraal gebruik
Paracox-5 Suspension pour suspension buvable
Paracox-5 Suspension zur Herstellung einer Suspension zum Einnehmen
Active substance:
  • Eimeria maxima, strain CP, Live
  • Eimeria tenella, strain HP, Live
  • Eimeria mitis, strain HP, Live
  • Eimeria maxima, strain MFP, Live
  • Eimeria acervulina, strain HP, Live
Target species:
  • Chicken (broiler)
  • Chicken (one day-old chick)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Eimeria maxima, strain CP, Live
    500.00
    Organisms
    /
    0.00
    millilitre(s)
  • Eimeria tenella, strain HP, Live
    1000.00
    Organisms
    /
    0.00
    millilitre(s)
  • Eimeria mitis, strain HP, Live
    100.00
    Organisms
    /
    0.00
    millilitre(s)
  • Eimeria maxima, strain MFP, Live
    200.00
    Organisms
    /
    0.00
    millilitre(s)
  • Eimeria acervulina, strain HP, Live
    500.00
    Organisms
    /
    0.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Chicken (broiler)
      • All relevant tissues
        0
        day
    • Chicken (one day-old chick)
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AN01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • box of 5 vials of 4 mL (1000 doses)
  • 1 vial of 500 mL (solvent)
  • 1 vial of 100 mL (solvent)
  • box of 5 vials of 20 mL (5000 doses)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Merck Sharp & Dohme Animal Health S.L.
  • MSD Animal Health UK Limited
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V211321 BE-V541635
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0351/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."